Lasry Marc’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Lasry Marc’s Portfolio IMPL Stock Details IMPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-225,874	Closed	-$97.1K	–	12
2023 Q3	$97.1K	Sell	225,874 -182,455	-45%	-$175K	0.1%	13
2023 Q2	$519K	Hold	408,329	–	–	0.67%	9
2023 Q1	$572K	Hold	408,329	–	–	1.1%	7
2022 Q4	$1.53M	Hold	408,329	–	–	2.38%	6
2022 Q3	$1.99M	Hold	408,329	–	–	3.82%	5
2022 Q2	$3.81M	Buy	408,329 +78,329	+24%	+$572K	5.79%	6
2022 Q1	$2.1M	Hold	330,000	–	–	1.05%	10
2021 Q4	$2.85M	Hold	330,000	–	–	1.41%	8
2021 Q3	$4.02M	Hold	330,000	–	–	2.48%	6
2021 Q2	$2.92M	Buy	+330,000	New	+$3.94M	1.35%	8

Other funds holding IMPL

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Lasry Marc's IMPL Position: Q4 2023 in Review

Lasry Marc sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 225,874 shares — an estimated $97.1K sold.

Lasry Marc first reported a position in IMPL in Q2 2021 and held it in 10 quarters. The position peaked at $4.02M in Q3 2021. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

Lasry Marc reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Lasry Marc sold 225,874 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $97.1K.
Lasry Marc first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Lasry Marc's Impel Pharmaceuticals Inc. Common Stock position peaked at $4.02M in Q3 2021.
2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on Lasry Marc's 13F filing for Q4 2023, filed 14 Feb 2024.